Doctor profile · Federal record
Dr. ELEANOR FORD, MD
Dermatology Physician (CMS: DERMATOLOGY) · SILVER SPRING, MD
- NPI 1396768560
- Accepts Medicare
- 46 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
344 UNIVERSITY BLVD W, # 321
SILVER SPRING, MD 20901
(301) 681-4233
fax (301) 681-4235
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- October 27, 2011
- Year of graduation
- 1980 — 46 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Maryland #D34589
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1396768560. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
599
Distinct HCPCS
8
Medicare allowed
$66,083
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 290 | 187 | $99 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 95 | 95 | $126 | |
17110 |
Destruction of skin growth, 1-14 growths | 92 | 73 | $129 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 51 | 49 | $144 | |
17000 |
Destruction of precancer skin growth, 1 growth | 22 | 18 | $59 | |
87101 |
Fungal culture (mold or yeast) of skin, hair, or nail | 19 | 15 | $8 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 19 | 19 | $184 | |
11102 |
Biopsy of related skin growth, first growth | 11 | 11 | $120 |
In context: peer comparison
Among 7 peers in this city , average services per provider: 165. This provider delivers 3.6× the peer median.Open Payments
Industry payments received
All-time total
$516
Transactions
18
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $120.43 | |
| Janssen Biotech, Inc. | 1 | $99.00 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $76.63 | |
| ABBVIE INC. | 3 | $64.27 | |
| PFIZER INC. | 2 | $42.90 | |
| Regeneron Healthcare Solutions, Inc. | 2 | $40.64 | |
| Lilly USA, LLC | 1 | $28.52 | |
| Novartis Pharmaceuticals Corporation | 1 | $21.72 | |
| Arcutis Biotherapeutics, Inc. | 1 | $21.47 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
178
Patients
33
Total drug cost
$109,272
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Minoxidil | Generic | 39 | 0 | $493 |
| Clobetasol Propionate | Generic | 29 | 15 | $2,097 |
| Triamcinolone Acetonide | Generic | 27 | 18 | $171 |
| Betamethasone Dipropionate | Generic | 22 | 0 | $713 |
| Otezla (Apremilast) | Brand | 17 | 0 | $79,532 |
| Desonide | Generic | 16 | 0 | $1,499 |
| Doxycycline Hyclate | Generic | 14 | 0 | $645 |
| Enstilar (Calcipotriene/Betamethasone) | Brand | 14 | 0 | $24,120 |